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ABSTRACT
Minimal plasmids play an essential 
role in many intermediate steps in 
molecular biology. For example, they 
can be used to assemble building 
blocks in synthetic biology or be used 
as intermediate cloning plasmids that 
are ideal for PCR-based mutagenesis 
methods. A small backbone also 
opens up for additional unique 
restriction enzyme cloning sites. Here 
we describe the generation of pICOz, 
a 1185-bp fully functional high-copy 
cloning plasmid with an extended 
multiple cloning site. We believe that 
this is the smallest high-copy cloning 
vector ever described.
METHOD SUMMARY
We eliminated all superfluous 
sequences in a commonly used 
cloning vector in order to generate as 
small a cloning plasmid as possible 
by simple iterative PCR mutagenesis.
Minimal plasmids have many uses and can 
either be generated synthetically [1] or by 
iterative deletions in an existing plasmid. 
The pUC family [2,3] of plasmids have been 
extensively used as a backbone for various 
cloning and expression vectors [4]. One of 
the most attractive features of the pUC 
family of plasmids is that they harbor a 
mutated pMB1 origin of replication (ORI), 
which leads to very high-copy replication of 
the plasmid [5].
Minimalism is an artistic as well as a 
functional design ideal [6] that provides 
enhanced robustness and utility in many 
fields of engineering (often referred to as 
the KISS principle, an acronym with many 
different interpretations but with the same 
essential meaning: keep it small and simple). 
The ideal is often summarized by a quote 
from the French poet Antoine de Saint 
Exupéry: “It seems that perfection is attained 
not when there is nothing more to add, but 
when there is nothing more to remove” [7]. 
In the software world, useless code and 
functions are often referred to as ‘bloat’, 
and some software projects have simplicity 
and minimalism as core values in their devel-
opment philosophy [8,9]. Just like useless 
and bloated code in software, superfluous 
genetic material in plasmids can cause 
‘bugs’, like the unintended eukaryotic 
transcription factor binding sites present in 
the pUC plasmids [10,11].
We have therefore applied the minimal-
istic philosophy in the design of a high-copy 
cloning plasmid backbone with as little ‘bloat’ 
as possible, which opens up for improved 
downstream applications. Minivectors 
have been found to be highly efficient 
for mammalian cell transfection [12] and 
in vivo for gene therapy [13]. Tiny plasmids 
are, however, not only found in a laboratory 
settings, replicating minimal plasmids 
down to 746 bp but have also been found 
in nature [14]. It is, however, still unclear 
how useful these natural minimal plasmids 
could be for molecular biology applications. 
Nevertheless, there may be further room for 
improvement with regards to miniaturization 
of useful artificial plasmids, which we invite 
the research community to explore further 
in an open, distributed manner.
MATERIALS & METHODS
Iterative deletions of pUC18
The plasmid was reduced in size in several 
different reaction (Rxn) steps by PCR as 
outlined in Table 1. Primers were obtained 
from Invitrogen. The in silico cloning, 
graphical vector map generation and 
sequence analyses were done in UGENE 
(http://ugene.net) [15]. Phusion DNA 
polymerase (New England Biolabs) PCR 
reactions were performed with the following 
general program: 3 min at 98°C denatur-
ation, 35x (10 s 98°C denaturation, 20 s at 
57°C annealing, 20 s/kbp at 72°C 
elongation), 10 min at 72°C. The Universe 
DNA polymerase (Biotool) PCR progam was 
5 min at 95°C denaturation, 35x (20 s at 95°C 
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denaturation, 20 s at 57°C annealing, 45 s/
kbp at 72°C elongation), 10 min at 72°C 
elongation on a GeneAmp 9700 (PE 
Biosystems) thermocycler. Ligation with T4 
DNA ligase (Promega) was performed at 
room temperature over night. CloneEZ 
(GenScript) reactions were performed for 
30 min at room temperature. All DNA 
products were transformed into competent 
MC1061 Escherichia coli by 30 s heat shock 
at 42°C in a water bath.
Determination of relative yield of 
plasmid variants
Yields of the plasmids pUC18 (LMBP 7874), 
pUC18deltaLacZ (LMBP 9213), pUCmu 
(LMBP 9329) and pICOz (LMBP 11103) were 
determined from MC1061 (LMBP 472), 
DH5α (Invitrogen), DH10B (Genome 
Systems), BL21 (Stratagene), Top10 (Invit-
rogen) and DB3.1 (LMBP 4098) E. coli 
strains (Table 2). Each plasmid was grown 
in quadruplicates starting from four 
individual clones picked from a plate for 
each host strain, and plasmids were 
prepped from 3 (MC1061) or 5 (other 
strains) ml culture per plasmid and repli-
cated using HQ Mini Plasmid Purification 
Kit (Invitrogen) (MC1061) or QIAprep Spin 
Miniprep Kit (QIAGEN) (other strains). DNA 
concentrations were determined by 
NanoDrop ND-8000 (ThermoFisher).
Verification, storage & distribution of 
DNA material
All plasmids in this study (Table 3) were 
deposited to the ISO 9001 [16] compliant 
BCCM/GeneCorner culture collection 
(www.genecorner.ugent.be). All plasmids 
were verified by Sanger sequencing 
(internal sequencing facility) and 
restriction enzyme digestion (Promega). 
Genbank sequence files for pUCmu and 
pICOz are provided in the supplemental 
data.
Table 1. Overview of primers used in the iterative shrinking of pUC18 into pICOz.













†Phusion DNA polymerase PCR, phosphorylated primers + T4 ligation.
‡Phusion DNA polymerase PCR, digestion + T4 ligation.
§Universe DNA polymerase PCR, CloneEZ recombination.
Bold text indicates novel restriction enzyme sites introduced by PCR.
Table 2. Overview of strains used in the plasmid DNA yield study.
Strain name Genotype Source




E. coli K12xB DB3.1 F-gyrA462 endA1 Δ(sr1-recA) mcrB mrr hsdS20 glnV44 (=supE44) ara14 galK2 lacY1 proA2 
rpsL20 xyl5 leuB6 mtl1
BCCM/GeneCorner 
(LMBP 4098)
E. coli K12 DH5α F- Δ(argF-lac)169 Φ80lacZΔM15ΔphoA8 glnX44(AS) λ-deoR481 rfbC1 gyrA96 recA1 endA1 
thiE1 hsdR17
Invitrogen
E. coli K12 DH10B F-mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara-leu)7697 galU 
galK rpsL (Str(R)) endA1 nupG
Genome Systems
E. coli K12 MC1061 F- Δ(araA-leu)7697 [araD139]B/r Δ(codB-lacI)3 galK16 galE15(GalS) λ
-e14-mcrA0 relA1 
rpsL150 spoT1 mcrB1 hsdR2
BCCM/GeneCorner 
(LMBP 472)
E. coli K12 TOP10 F-mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 Δ lacX74 recA1 araD139 Δ(araleu)7697 galU 
galK rpsL (StrR) endA1 nupG
Invitrogen
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RESULTS & DISCUSSION
Generation of a minimal cloning plasmid 
with an extended multiple cloning site
In order to shrink a high-copy and widely 
used cloning backbone like pUC18, we 
sequentially eliminated code segments that 
we identified as unnecessary or ‘useless 
bloat’. ‘Unnecessary’ is naturally a question 
of definition and context, where for example 
the LacZ present in the original pUC18 vector 
can be useful for performing blue/white 
selection during cloning. However, remnants 
of this sequence in expression vectors or 
when clone selection is done by colony PCR 
(for example, blue/white selection does not 
work in the MC1061 strain) makes this 
sequence unnecessary for many purposes. 
Consequently, the first reaction (Rxn1; 
Figure 1) eliminated LacZ and some 
additional sequence upstream of the pBla 
promoter driving Ampicilin resistance. The 
eliminated sequence was replaced by some 
additional restriction enzyme sites (MluI, 
NruI, SfiI, NdeI, NcoI, MscI; Figure 2) that 
were added to the multiple cloning site 
(MCS). This resulted in pUC18deltaLacZ, 
which is 496 bp smaller than the pUC18 
parental plasmid.
In the second reaction (Rxn2, Figure 1), 
we eliminated additional parts of the LacZ 
promoter and useless code between the 
MCS and the ORI from pUC18ΔLacZ, and 
this sequence was replaced by additional 
restriction enzyme sites in the MCS (EcoRV, 
XhoI, SpeI, ApaI, PmeI; Figure 2). By random 
Table 3. Overview of plasmids used in this study.
Plasmid name Source BCCM/GeneCorner accession number
pUC18 [2] LMBP 7874
pUC18deltaLacZ This study LMBP 9213
pUCmini This study LMBP 9221
pUCmu This study LMBP 9329
pU6mu This study LMBP 9491
pU6z This study LMBP 11144
pdITz This study LMBP 11273
pICOz This study LMBP 11103
pICOz-Flag-bio-mCARD11 This study LMBP 11222
pICOz-Flag-hCARD14 This study LMBP 11223
pICOz-Flag-hCARD9 This study LMBP 11224












































































Figure 1. Overview of the cloning scheme for generation of a minimal vector backbone.  
(A) Graphical overview of the modifications made in each step in the miniaturization process. 
Rxn = reaction. Red lines indicate area that was modified in the following reaction, where the ends 
of the lines indicate the position of the primers used for that reaction and the black arrows indicate 
the primers from Table 1. Green plasmid elements indicate the annotated ORI in the plasmid; grey 
plasmid elements are ‘useless’ annotated elements; blue plasmid elements indicate antibiotic 
selection marker; red plasmid elements indicate annotated prokaryotic transcription terminators. 
The pink lines in pUC18, pUC18∆LacZ and pUCmini indicate the location of the RNAII transcript, 
which is important for plasmid replication [5] but not included in the pMB1 ORI annotation. The new 
ORI annotation (in pUCmini, pUCmu and pICOz) after the pUCmini deletion event includes the RNAII 
transcript. (B) HindIII digest (indicated by ‘+’) of 1 μg pUC18, ΔlacZ (=pUC18∆LacZ), pUCmu and 
pICOz run on a 1% Agarose/TAE gel. Sizes on the SmartLadder (Eurogentec) indicated in kbp (‘k’).
ORI: Origin of replication.
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chance, a clone that was picked up showed 
a deletion in the pUC ORI and part of the MCS 
without showing any detrimental effects on 
plasmid yield. This event most likely was 
due to an alternative recombination reaction 
instead of the intended ligation of the plasmid 
PCR product. This plasmid was designated 
pUCmini, which is 432 bp smaller than the 
pUC18∆LacZ parental plasmid.
In order to shrink the plasmid further, an 
additional region with unnecessary genetic 
code was identified between the ampicillin 
resistance and the ORI, and a deletion 
was made to make the resistance marker 
use a terminator sequence present in the 
ORI (Rxn 3, Figure 1). Since the pUCmini 
plasmid also had a deletion in the MCS, we 
also repaired the MCS to restore the lost 
restriction enzyme sites (Rxn 4, Figure 1). 
The resulting pUCmu plasmid ended up 
being 89 bp smaller than pUCmini but 
with a complete extended MCS. After this 
reaction, no ‘useless bloat’ genetic code 
could be identified in the sequence and the 
only way to safely shrink the plasmid further 
was by replacing the antibiotic selection 
marker with a smaller one using overlap 
extension cloning [17] or recombination-
based cloning. As a proof-of-concept, we 
replaced ampicillin resistance with zeocin 
resistance by amplifying the pUCmu plasmid 
without the ampicillin resistance sequence 
(Rxn 5, Figure 1) and recombined this PCR 
product with a PCR-amplified zeocin resis-
tance gene (Rxn 6) using CloneEZ. In 
parallel, a PCR-based fusion between the 
two fragments was equally successful. The 
resulting pICOz plasmid is 484 bp smaller 
than the minimal pUCmu parental plasmid. 
With these four sequential steps of elimi-
nation, we have thus been able to reduce 
the 2686-bp pUC18 plasmid to the 1185-bp 
pICOz plasmid, which contains more 
useable cloning sites, a total size reduction 
of 56%.
Despite the history of a random deletion 
event during the generation of this minimal 
plasmid, inserts cloned and propagated in 
the pICOz minimal backbone are stable. 
We have cloned several cDNAs in pICOz 
as an intermediate step for PCR-based 
mutagenesis (e.g., MALT1 [LMBP 11225], 
CARD9 [LMBP 11224], CARD11 [LMBP 
11222] and CARD14 [LMBP 11223]), which 
remain stable after multiple rounds of propa-
gation. We have also generated generally 
useful vector backbones with a large insert, 
like pdITz (LMBP 11273), which contains 
sleeping beauty transposon arms and a 
multi-site gateway destination cassette, and 
vectors with very small inserts like the pU6z 
(LMBP 11144), which contains a cloning site 
for SpCas9 CRISPR guideRNA expression 
behind the U6 promoter. As a demonstration 
of stability after several rounds of amplifi-
cation of these generally useful vectors, we 
test-digested pdITz and pU6z (Figure 3).
Determination of absolute & relative 
yield of the minimal cloning plasmids
In order to verify that the deletions had not 
eliminated anything that would impact 
plasmid copy number and total yield, we 
carried out several parallel heat shock E. coli 
transfections and mini plasmid preparations 
of four constructs (pUC18, pUC18∆LacZ, 
pUCmu and pICOz). Surprisingly, pUCmu and 
pICOz show a very high yield both in absolute 
amount of DNA produced from an overnight 
culture (Figure 4A) and even more so when 
factoring in that these plasmids are much 
smaller than the pUC18 parental plasmid 
(Figure 4B).
Generation of a minimal cloning plasmid 
– how small can we go?
We describe the generation of a minimal 
∼1-kb fully functional cloning plasmid, 
which is as far as we currently can get in 
miniaturization. All unnecessary 
sequences have been eliminated and there 
is no additional space between the MCS, 
ORI and selectable marker (Figure 1). We 
now use the smallest widely used resis-
tance marker and the only way to shrink 
the plasmid further is to do additional 
deletion/engineering of the ORI or replace 




Figure 2. Comparisons of the original pUC18 MCS compared with the extended MCS in pUCmu and 
pICOz. Restriction sites are indicated in alternating red and black text for clarity. Overlapping  





























Figure 3. Verification of stability of pICOz-based clones that have been propagated several times. 
The pU6z plasmid was linearized with NcoI, resulting in a 1553-bp band. To verify the integrity of the 
remaining MCS next to the insert, a HindIII/BglI double digest cutting in the MCS and the Zeo resis-
tance gene was done, resulting in 1143-bp and 410-bp bands (arrows). Similarly, the pdITz plasmid 
with a larger insert was linearized with NotI resulting in a 3534-bp band, and part of the insert was 
cut out with HindIII, resulting in a 2085-bp and a 1449-bp band (arrows). Sizes on the SmartLadder 
(Eurogentec) indicated in kbp (‘k’).
Reports
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By lucky coincidence, we managed to 
identify a random deletion mutant of the 
pUC variant of the pMB1 ORI, which shrunk 
the pUC ORI from 750 bp to 616 bp. A 
minimal pUC-derived ORI of 674 bp 
(GenBank: EU496091.1) has been described 
in the BioBrick system [18]. Sequence 
comparisons reveal alignment between 
pICOz and base 3–618 of the BioBrick pUC 
ORI. The alignment also revealed that the 
BioBrick pUC contains a few point 
mutations to eliminate restriction sites in 
the ORI. Our minimal backbone could in 
principle very easily be made completely 
synthetically, where all restriction sites in 
the backbone in theory could be eliminated 
and the MCS be further extended. This 
could be one very interesting future 
prospect for further development of the 
pICOz backbone as a standard IGEM ‘part’ 
for synthetic biology [19,20]. Our random 
deletion pUC ORI mutant is likely to be 
almost the most minimal variant of the pUC 
ORI that can be generated, since RNAII 
(27–615 bp on the BioBrick genbank 
annotation) is absolutely needed, and the 
remaining upstream flanking bases (3–27 
on the BioBrick genbank annotation) are 
most likely required for the expression of 
the RNAII. Despite being required for 
plasmid replication, RNAII is sometimes 
not included in the pUC ORI (pMB1) 
annotation (Figure 1). A minimal ORI from 
the low-copy plasmid pSC101 of only 
220 bp has been described [21]. In theory 
it should be possible to shrink pICOz to 
789 bp with this minimal ORI if it works 
without additional sequences like pUC ORI 
depends on RNAII. With our 1185 bp, we 
are however already very close to the 
smallest plasmid ever found in nature 
(746 bp), and we usually need a high-copy 
plasmid and a selectable marker to have 
a useful cloning vector, which currently 
restricts further size optimization. Other 
use-cases could however require low-copy 
plasmids (e.g., for E. coli protein 
expression) and in those cases additional 
size optimizations such as the pSC101 ORI 
could be interesting. The selectable 
marker unconditionally adds at least 
458 bp (promoter + coding domain 
sequence [CDS] + terminator), so it might 
be that we are already at the lowest limits 
of what can be obtained for a fully 
functional high-copy cloning vector in 
E. coli.
Practical use-cases of a small  
cloning plasmid
There are several potential use-cases for a 
tiny plasmid backbone. One very useful 
use-case is to use pICOz as an intermediate 
cloning plasmid for PCR-mediated 
mutagenesis and then clone the generated 
mutant into the expression vector. This has 
three major advantages: 1) The PCR only 
needs to amplify a small product 
(insert + 1 kb) rather than the entire 
expression vector (typically insert + 5–6 kb 
for mammalian expression vectors); 2) there 
is no risk that the PCR amplification has 
caused any unintended modifications to the 
expression vector; and 3) since most 
expression vectors are ampicillin resistant, 
cloning from the zeocin-resistant interme-
diate pICOz vector reduces the risk of 
contamination from the parental pICOz 
vector. The pICOz and pUCmu vector 









































































Figure 4.  Yield comparisons of minimal plasmids vs parental plasmids in multiple E. coli strains.  
(A) Absolute yield (μg/ml overnight culture) for the four constructs. (B) Plasmid size-
adjusted relative yield (average pUC18 yield set to 1) and divided by relative size (pUC18 = 1, 
pUC18∆LacZ = 0.81, pUCmu = 0.62 and pICOz = 0.44). The plasmid size-adjusted yield should 
be correlated with number of plasmid molecules extracted/ml of overnight culture. Error bars 
represent 95% confidence intervals.
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eukaryotic expression vector backbones in 
some cases. However, adding a complete 
mammalian expression casette and SV40 
origin of replication defeats the purpose of 
the tiny backbone since the few kb saved on 
the backbone will make little difference on 
the final size of the expression vector. There 
are however use-cases with much smaller 
expression casettes, for example CRISPR/
Cas9 guideRNA expression from the U6 
promoter and terminator (e.g., pU6mu LMBP 
09491 and pU6z LMBP 11144). Expression 
of these guide RNAs are also preferably 
transient, so we do not need the SV40 origin 
of replication. We have experienced that 
some cells are more easily transfected 
with small expression plasmids 
(e.g., electroporation of Jurkat T cells) and 
this has also been shown by others [12], 
which means that these small expression 
plasmids can have a practical use-case. 
There are however many more potential 
use-cases of these small vector back bones 
in many fields of molecular biology and we 
encourage creative use of this tool to develop 
novel downstream applications.
FUTURE PERSPECTIVE
We highly encourage others to further 
improve on our best attempt to generate a 
minimal core cloning plasmid. Distributed 
development has been shown to be an 
extremely powerful force in open source 
software development [22], and genetic 
material shows many commonalities with 
software in that it can be copied and repro-
duced very easily [23]. People developing 
this backbone further are naturally free to 
explore and adapt it in any way they see fit. 
An interesting future tactic would however 
be to further explore alternative ORI and 
selectable markers in this vector backbone 
to try to shrink it further. Also extending the 
MCS and making a synthetic ‘un-cleavable’ 
pICOz backbone is a very interesting idea for 
future development. Other optimization 
aspects than size and cloning properties 
could also be interesting. For example, 
nonantibiotic selectable markers (like 
Zn2+ [24], Cu2+ [25], Ag+ [26] or high-salt [27] 
resistance) could be highly interesting to 
explore for E. coli cloning vectors.
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